The incidence of thyroid cancer is rapidly increasing, mostly due to the overdiagnosis and
overtreatment of differentiated thyroid cancer (TC). The increasing use of potent preclinical …

Objective Larotrectinib is a highly selective tropomyosin receptor kinase (TRK) inhibitor with
demonstrated efficacy across various TRK fusion-positive solid tumours. We assessed the …

The incidence of thyroid nodules (TNs) is estimated at 36.5% and 23% in females and
males, respectively. A single thyroid nodule is usually detected during ultrasound …

Background The extent of thyroid surgery remains controversial for differentiated thyroid
cancers (DTCs) that measure more than 1 cm but are not considered high risk. This study …

Abstract Objective Dipeptidyl peptidase IV (DPP4) has been indicated as a possible
prognostic biomarker in papillary thyroid cancer (PTC). However, the mechanism of DPP4 …

Thyroid cancer is the most frequent endocrine malignancy, which accounts for nearly 1% of
all the cancer worldwide. Crocin has a diverse biological function, such as anti‐cancer, anti …

Thyroid cancer surgery has evolved dramatically with advances in our understanding of the
biological behaviour of WDTC. Molecular profiling is shedding light on the subset that may …

The transcription factor, forkhead box P2 (FOXP2) has tumor‑suppressive effects in several
types of cancer. However, the regulatory role and underlying mechanism of FOXP2 in …

Thyroid cancer (TC) is the most prevalent endocrine malignancy. More than 90% of TC is
represented by differentiated TC (DTC) arising from the follicular thyroid cells. DTC includes …

Thyroid neoplasms requiring differential diagnosis between thyroid cancer and benign
tumors can be detected in more than half of the healthy population. A generally accepted …